U.S. Clears Seroquel for Bipolar Depression
Medscape News - LONDON (Reuters) Oct 20 - AstraZeneca Plc said on Friday it had won U.S. approval for Seroquel (quetiapine) to be sold as treatment for bipolar depression. The antipsychotic drug had already been cleared by the Food and Drug Administration as a
Source: www.medscape.com
Preliminary Program: Saturday, May 19
Psychiatric News - Neurobiology of Bipolar Depression: Implications for Treatment Robert M. Post, M.D. New Treatment Options for Bipolar Depression Marcia L. Verduin, M.D. Clinical Correlates Associated With Treatment-Emergent Mania Mark A. Frye, M.D. The Clinical Interface
Source: pn.psychiatryonline.org
Click here for more information about zoloft depression medication zoloft depression medication
<< Home